Mantle cell lymphoma (MCL) is a subtype of Non-Hodgkins Lymphoma (NHL) with varying clinical presentations, ranging from indolent disease to highly aggressive symptoms. MCL represents approximately 3-10% of non-Hodgkin lymphomas, and has increased in incidence over the past several decades. The majority of patients respond to initial therapy, but remission duration is typically short. This book discusses the clinical characteristics of mantle cell lymphoma, as well as its prevalence and examines several treatment options available.
Preface; Diagnosis, Prognosis & Genetic Features of Mantle Cell Lymphoma; Mantle Cell Lymphoma:: Current Treatment Strategies in the Era of Targeted Agents; Targeted Drugs in the Treatment of Mantle Cell Lymphoma; Emerging Role of Novel Agents in the Treatment of Mantle Cell Lymphoma; Current Place of Proteasome Inhibitors in the Treatment of Mantle Cell Lymphoma; Index.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.